After achieving promising outcomes for patients with sleep apnea, Eli Lilly said April 17 it plans to seek a wider FDA approval for Mounjaro and Zepbound.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Eli Lilly to seek label expansion for Mounjaro, Zepbound
